Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 1;28(1):e270-e273.
doi: 10.1097/RHU.0000000000001618.

Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent

Christopher Banse, Estelle Houivet  1 , Aurélien Loison  2 , Rémi Varin  2 , Sophie Pouplin  3 , Thierry Lequerré  3 , Olivier Vittecoq  3
Affiliations

Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent

Christopher Banse et al. J Clin Rheumatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Radner H, Yoshida K, Mjaavatten MD, et al. Development of a multimorbidity index: impact on quality of life using a rheumatoid arthritis cohort. Semin Arthritis Rheum . 2015;45:167–173.
    1. Radovits BJ, Fransen J, Al Shamma S, et al. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis. Arthritis Care Res (Hoboken) . 2010;62:362–370.
    1. Nguyen-Khoa BA, Goehring EL Jr., Alexander KA, et al. Risk of significant infection in rheumatoid arthritis patients switching anti–tumor necrosis factor-α drugs. Semin Arthritis Rheum . 2012;42:119–126.
    1. Humphreys J, Hyrich K, Symmons D. What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? Arthritis Res Ther . 2016;18:282.
    1. Sugihara T, Harigai M. Targeting low disease activity in elderly-onset rheumatoid arthritis: current and future roles of biological disease-modifying Antirheumatic drugs. Drugs Aging . 2016;33:97–107.

MeSH terms

LinkOut - more resources